多次挂牌无人问津，永和智控继续“割肉甩卖”

Core Viewpoint - Yonghe Intelligent Control is struggling to sell its assets, as evidenced by multiple unsuccessful attempts to transfer its subsidiaries, leading to significant price reductions in the latest offerings [1][2][3]. Group 1: Asset Sales - Yonghe Intelligent Control announced the fifth attempt to publicly transfer 51% of its subsidiary, Puluo New Energy Technology (Taixing) Co., Ltd., after four previous attempts failed to attract any bidders. The starting price for this attempt has been reduced by 80% to 609.80 million yuan [2]. - The company is also attempting to transfer 100% of its subsidiary, Kunming Medical Oncology Hospital Co., Ltd., for the third time, with the price lowered by 40% to 2155.662 million yuan after two unsuccessful attempts [3]. Group 2: Financial Performance - Yonghe Intelligent Control has faced financial difficulties, reporting net losses of 0.27 billion yuan, 1.56 billion yuan, and 2.97 billion yuan for the years 2022 to 2024, respectively [4]. - In the third quarter of 2025, the company reported a revenue of 582 million yuan, a year-on-year decrease of 7.25%. The net loss for the same period was 60.46 million yuan, a slight improvement from the previous year's loss of 76.20 million yuan [6].